Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Abbey Higginbotham
Benzinga Staff Writer
About
Abbey Higginbotham, Benzinga's Events Columnist, covers the latest in cannabis, digital assets and fintech. Drawing from her print and broadcast journalism experience, she provides up-to-date event coverage.
California's Hemp Restrictions Spark Industry Debate: 'Banning This Category Is Better For The Market,' Says Expert
California's emergency hemp ban raises concerns about impact on businesses and consumers. It could also influence future regulations on THC products nationwide.
Will California's Hemp Ban Cost The State Billions? 'Just The Drink Category Is Worth Over A Billion' Says Expert
Gov. Newsom's emergency order restricting hemp products sparks concerns and potential multi-billion dollar losses in California.
California's Hemp Ban 'Likely Won't Be The Last': Will It Push Consumers Back To Licensed Operators?
California's emergency hemp rules raise concerns in cannabis industry. Impact on legal market and potential federal changes could create challenges and losses for businesses. Uncertainty prevails as industry leaders prepare for a changing regulatory environment.
Adult-Use Markets 'Don't Meet Needs Of All Patients': The Overlooked Role Of Medical Marijuana
Founder of Standard Wellness Maryland offers insights on the importance of maintaining robust medical cannabis laws.
California's New Hemp Rules Could Reshape Cannabis: 'A Different Set Of Rules In Every State'
California's new restrictions on the sale of hemp products have sparked debate within the cannabis community.
'Companies With Distinctive Brands Are Gaining Attention': What's Driving Cannabis Investment Today?
Investors prioritize financial performance and market presence in evaluating cannabis companies. Brand strength and customer loyalty are also key factors.
How Will California's Hemp Restrictions Change The Cannabis Market: 'There Is A Risk Of This Activity Flooding The US' Says Expert
Proposed restrictions on hemp products in California could impact the entire U.S. market. CEO Will Bowden hopes for similar regulations in other states.
Medical Marijuana's Role In Cannabis Reform: Why It Can't Be Ignored
The importance of medical marijuana is often overshadowed in cannabis policy discussions. It remains crucial for patients and has potential for global reform. Continued advocacy is needed to keep it at the forefront.
Medical Marijuana Takes A 'Back Seat' As Adult-Use Legalization Gains Momentum
Medical marijuana is losing attention in the cannabis industry, raising concerns about its future and impact on patients. Policy changes may further sideline it.
'No Companies Will Invest': How California's Hemp Rules Could Hurt Cannabis Businesses
California's hemp industry facing shakeup as Newsom's limits on hemp sparks debate and potential ripple effects nationwide.
'Get Ready For A Nationwide Game Of Whack-A-Mole': What California's Hemp Ban Means For The Industry
The ban will impact hemp businesses in California, particularly those selling certain beverages and other hemp-related products, sources say.
Zero DTE Options Fuel Record SPX Trading Volumes, With No Signs Of Slowing Down: Expert
Zero Days to Expiration options now account for nearly 47% of SPX trading volume in 2024, Robert Hocking says.
Cannabis Investors 'Actively Chasing' Companies Expanding Beyond The Industry Says Expert
The cannabis industry is facing increasing financial pressure as investors become more selective with their capital.
Has Medical Marijuana Been Forgotten In Cannabis Reform? 'Its Therapeutic Benefits Are Critical'
Medical marijuana's role in cannabis reform is overlooked despite pioneering legalization.
'Catalyst States Are Hot': What's Driving Cannabis Investments In Key Markets
As cannabis industry matures, investors focus on cash flow and growth potential.
'Medical Marijuana is Still Critical': Balancing Act Between Recreational, Medicinal Markets
Cannabis reform is moving forward, but medical marijuana is often overshadowed by recreational use. State-level policies and tax incentives play big roles.
California's Hemp Restrictions Could 'Stifle Broader Access' To Therapeutic Products, Expert Warns
"Governor Newsom's proposed restrictions could have significant ripple effects across the cannabis industry," Ispire's Luna Stower says.
Cannabis Reform On The Horizon, But 'Lasting Change' Requires More Than Promises
Political developments could shape cannabis market's future. Real progress will require bipartisan legislation. Rescheduling may impact banking.
'Investors Are Looking Beyond The Hype': What's Driving Cannabis Investments Today?
Cannabis companies are focusing on demonstrating long-term financial health and a commitment to social responsibility.
Rescheduling Cannabis: What The First Pro-Legalization Presidential Ticket Could Mean For The Industry
2024 election brings potential for federal cannabis rescheduling. Harris-Walz ticket marks crucial moment for industry.